FibroGen Inc (FGEN) — Capital Reinvestment Ratio
FibroGen Inc (FGEN) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($12.68 Million) in capital expenditures ($13.00K). See FGEN equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
FibroGen Inc Capital Reinvestment Ratio (2013–2020)
This chart tracks FibroGen Inc's Capital Reinvestment Ratio across 4 annual periods. Check FGEN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for FibroGen Inc (2013–2020)
Year-by-year Capital Reinvestment Ratio for FibroGen Inc from 2013 to 2020. For live market cap and broader valuation context, see FibroGen Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.05x | $81.60 Million | $3.99 Million | ▼ -72.2% |
| 2016 | 0.18x | $7.11 Million | $1.25 Million | ▼ -51.4% |
| 2014 | 0.36x | $22.41 Million | $8.12 Million | ▲ +37.9% |
| 2013 | 0.26x | $25.92 Million | $6.81 Million | — |